Fate Therapeutics Inc
NASDAQ: FATE
$2.21
+$0.14 (+6.8%)
Real Time Data Delayed 15 Min.
FATE Stock Chart and Intraday Price
FATE Stock Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Address | 3535 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 768.10M USD |
| Shares Outstanding | 99,238,000 |
FATE Articles
Tuesday's top analyst upgrades and downgrades included American International Group, APA, Etsy, Goldman Sachs, Howmet Aerospace, Morgan Stanley, Wayfair, Welltower, Wendy’s and Workday .
Published:
Last Updated:
Friday’s top analyst upgrades and downgrades included Analog Devices, Bath & Body Works, Cisco Systems, Elanco Animal Health, Exxon Mobil, Marvell Technology, MGIC Investment, Nvidia, Snowflake,...
Published:
Monday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Cheniere Energy, Chewy, Costco Wholesale, CrowdStrike, Exact Sciences, Lululemon Athletica, New York Community Bancorp,...
Published:
Friday’s additional top analyst upgrades and downgrades were on BankUnited, Canadian National Railway, Fate Therapeutics, Moody's, Regions Financial, Snowflake, Travelers, Voya Financial and more.
Published:
Wednesday afternoon's top analyst upgrades and downgrades included Advanced Micro Devices, Analog Devices, Applied Materials, Comcast, Chipotle Mexican Grill, Grab, IBM, Johnson & Johnson, Lyft,...
Published:
Tuesday afternoon's analyst upgrades and downgrades included Fate Therapeutics, Livent, RealReal, SmileDirectClub and more.
Published:
Thursday's top analyst upgrades and downgrades included Dick’s Sporting Goods, Fate Therapeutics, Kimberly-Clark, Nordstrom, Roblox, TJX Companies and Zoom Video Communications.
Published:
A couple of Cathie Wood's ARK Invest funds bought over 240,000 shares of Fate Therapeutics on August 3.
Published:
One of Cathie Wood's Ark Invest funds bought over 530,000 shares of Fate Therapeutics on July 7.
Published:
Monday's top analyst upgrades and downgrades included Capital One, Etsy, Fiserv, Progessive, Splunk, Ulta Beauty and Visa.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Etsy, Fate Therapeutics, Intellia, Ionis, Monster Beverage and more.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Alexion Pharma, Activision Blizzard, Baker Hughes, BioMarin, and more.
Published:
Friday's top analyst upgrades and downgrades included AIG, Best Buy, Carvana, Dell Technologies, HP, L Brands, Monster Beverage, Twitter and Zscaler.
Published:
Wedbush took a closer look at some of the companies in its coverage universe that are set to present at ASCO and what the impact may be going forward.
Published:
Wednesday's top analyst upgrades and downgrades included Bluebird Bio, Ciena, CommVault Systems, Dollar General, JD.com, Kroger, Nucor, Target and Walmart.
Published:
Last Updated: